Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatment. [electronic resource]
Producer: 20150406Description: 61-8 p. digitalISSN:- 1532-1967
- Animals
- Antibodies, Monoclonal, Humanized -- pharmacology
- Antineoplastic Agents -- pharmacology
- Bone Density Conservation Agents -- pharmacology
- Bone Diseases -- immunology
- Bone Neoplasms -- drug therapy
- Bone Remodeling -- immunology
- Bone Resorption -- immunology
- Bone and Bones -- immunology
- Clodronic Acid -- pharmacology
- Denosumab
- Diphosphonates -- pharmacology
- Humans
- Ibandronic Acid
- Imidazoles -- pharmacology
- Immune System
- Osteoclasts -- drug effects
- Osteoprotegerin -- drug effects
- Pamidronate
- RANK Ligand -- antagonists & inhibitors
- Receptor Activator of Nuclear Factor-kappa B -- drug effects
- Signal Transduction -- drug effects
- Treatment Outcome
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.